Annual Shareholders Equity
$5.72 M
-$2.68 M-31.87%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual stockholders equity is $5.72 million, with the most recent change of -$2.68 million (-31.87%) on December 1, 2023.
- During the last 3 years, RVPH annual shareholders equity has risen by +$253.00 thousand (+4.63%).
- RVPH annual shareholders equity is now -80.06% below its all-time high of $28.69 million, reached on December 31, 2021.
Performance
RVPH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$9.98 M
-$3.94 M-65.22%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly stockholders equity is -$9.98 million, with the most recent change of -$3.94 million (-65.22%) on September 1, 2024.
- Over the past year, RVPH quarterly shareholders equity has dropped by -$1.46 million (-17.17%).
- RVPH quarterly shareholders equity is now -128.92% below its all-time high of $34.52 million, reached on June 30, 2021.
Performance
RVPH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RVPH Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.9% | -17.2% |
3 y3 years | +4.6% | -715.7% |
5 y5 years | +184.0% | -715.7% |
RVPH Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -80.1% | at low | -134.8% | at low |
5 y | 5-year | -80.1% | +184.0% | -128.9% | at low |
alltime | all time | -80.1% | +184.0% | -128.9% | at low |
Reviva Pharmaceuticals Holdings Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$9.98 M(+65.2%) |
Jun 2024 | - | -$6.04 M(+348.9%) |
Mar 2024 | - | -$1.35 M(-123.5%) |
Dec 2023 | $5.72 M(-31.9%) | $5.72 M(-167.1%) |
Sep 2023 | - | -$8.52 M(-625.5%) |
Jun 2023 | - | $1.62 M(-72.0%) |
Mar 2023 | - | $5.79 M(-31.1%) |
Dec 2022 | $8.39 M | $8.39 M(-58.8%) |
Sep 2022 | - | $20.36 M(+26.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $16.06 M(-24.8%) |
Mar 2022 | - | $21.36 M(-25.5%) |
Dec 2021 | $28.69 M(+424.8%) | $28.69 M(-11.1%) |
Sep 2021 | - | $32.27 M(-6.5%) |
Jun 2021 | - | $34.52 M(+664.3%) |
Mar 2021 | - | $4.52 M(-17.4%) |
Dec 2020 | $5.47 M(-180.2%) | $5.47 M(-81.6%) |
Nov 2020 | - | $29.65 M |
Dec 2019 | -$6.81 M | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual shareholders equity year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly shareholders equity year-on-year change?
What is Reviva Pharmaceuticals Holdings annual stockholders equity?
The current annual shareholders equity of RVPH is $5.72 M
What is the all time high annual shareholders equity for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual stockholders equity is $28.69 M
What is Reviva Pharmaceuticals Holdings annual shareholders equity year-on-year change?
Over the past year, RVPH annual stockholders equity has changed by -$2.68 M (-31.87%)
What is Reviva Pharmaceuticals Holdings quarterly stockholders equity?
The current quarterly shareholders equity of RVPH is -$9.98 M
What is the all time high quarterly shareholders equity for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly stockholders equity is $34.52 M
What is Reviva Pharmaceuticals Holdings quarterly shareholders equity year-on-year change?
Over the past year, RVPH quarterly stockholders equity has changed by -$1.46 M (-17.17%)